FAQ • Register (In-Person or Virtual!) • Schedule • Posters • Resources • Engage/Mentoring • Students • Destination • Sponsorships • Planning Committee

Product Theater
Forging a New Path: Targeting Muscarinic Receptor Circuits in Schizophrenia
Supported by Karuna

Registration Options

Sign in (or create a FREE account) to register for FREE!
Or get even more great content when you register for the meeting!

Session Time and Location

Date: Tuesday, 04/18/2023

Time: 10:30 AM (view in the schedule)

Room: Centennial I, and virtual

Session Summary

Prior to the presentation, lunch will be served from 11:15-11:30 AM Eastern. The program should begin right at 11:30 AM Eastern; however, small delays are possible due to the meal. We thank you in advance for your patience.

Currently approved drugs for schizophrenia have proven useful; however, unmet medical needs still exist for this patient population. This program will shed light on an evolving class of investigational therapeutics that have shown great promise in schizophrenia by targeting muscarinic acetylcholine receptors in the brain.

Faculty Information and Disclosures

Jose Rey, MS, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Illustrate the evolving understanding of the psychopharmacology of schizophrenia with respect to muscarinic receptor–based mechanisms of action
  2. Introduce muscarinic receptor–modulating therapeutics currently under investigation for use in schizophrenia with a focus on muscarinic agonists
  3. Demonstrate how modulating muscarinic receptor activity may play a role in treating schizophrenia

Grant Support

Supported by